Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies
暂无分享，去创建一个
M. H. Le | T. Asselah | P. Kwo | K. Kowdley | E. Gane | Samuel S. Lee | F. Mensa | F. Poordad | K. Nguyen | P. Thuy | A. Abergel | F. Wong | L. Fredrick | C. W. Spearman | G. Schnell | Tuan T. Nguyen | Betty B. Yao | C. George | Manh Hung Le